Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Women treated for breast cancer are at increased risk for cardiovascular disease, including
heart failure. In this study, by using magnetic resonance imaging (MRI), the investigators
want to assess if heart failure medications such as beta blockers and angiotensin receptor
blockers can prevent cardiac dysfunction during early breast cancer therapy.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Akershus
Collaborators:
AstraZeneca Norwegian Cancer Society University of Oslo